Articles tagged with Lungs
A study of over 2.9 million patients found that gender concordance was associated with lower mortality for female patients, but higher mortality for male patients. The quality of surgical care provided by female surgeons is equivalent to or slightly better than that provided by male surgeons.
Researchers have engineered a living material resembling human phlegm to study polymicrobial biofilms in cystic fibrosis patients. The material, which grows 3D biofilms in a controlled manner, will help experts understand how these structures form and develop effective treatments.
A recent study published in Nature Communications reveals that disrupted NAD(H) homeostasis is a key factor in tuberculosis pathogenesis. The researchers found that the glycolytic pathway can be selectively inhibited using an LDH enzyme with mostly LDHA subunits, which preferentially converts pyruvate to lactate and NADH to NAD+.
Researchers developed soft, miniaturized wearables that continuously track subtle body sounds wirelessly across the body. The devices offer new functionalities and provide highly accurate, real-time evaluation of patient health.
The November issue of CHEST journal features cutting-edge research on asthma, COPD, diffuse lung disease, and thoracic oncology. A new guideline provides updated recommendations for patients with stable COPD, while home spirometry is shown to be less consistent than clinic spirometry in monitoring lung function in patients with asthma.
Researchers aim to identify contaminants in ash, soil, and surface waters from the Maui fire, posing risks to human health. The study will also help educate communities on the presence and risk of contaminants, informing prevention measures for future fires.
Researchers discovered COVID-19 causes epigenetic scars in lung tissue that lead to hyperinflammation and fibrosis. These changes are associated with increased interferons and chemokines, promoting inflammation.
Researchers at Brigham and Women's Hospital analyzed data from over 7,500 patients to discover that suspected bronchiectasis in smokers is associated with a higher risk of mortality. The study suggests that lung imaging can help identify this condition, leading to improved patient care.
A large-scale study found that low-dose CT screening increases the 20-year survival rate of lung cancer patients from 18.6% to 81%, with Stage I cancers having an even higher long-term survival rate of 95%. Early detection through annual screening can effectively cure lung cancer in the long term.
A new study published in Radiology shows that patients diagnosed with lung cancer via CT screening have a 20-year survival rate of 81 percent, significantly higher than the average five-year survival rate for all lung cancer patients. Early detection through routine screening can lead to a cure if found early.
A new study by RCSI University of Medicine and Health Sciences found that boosting levels of a deficient protein improves survival rates for people with severe alpha-1 antitrypsin deficiency. The research, which tracked health data from over 600 patients, showed a clear survival benefit from augmentation therapy.
Dr. Marlene Rabinovitch, a renowned pediatric cardiologist, will receive the 2023 Research Achievement Award for her groundbreaking research on PAH treatment. Her discoveries have led to the identification of neutrophil elastase as a trigger for inflammatory responses and the potential use of immunosuppressant FK506 to restore lung blo...
Researchers identify immune cells responsible for some hard-to-treat asthma cases, particularly in men who develop asthma later in life. These cells can cause severe inflammatory responses and do not respond to treatment.
Researchers identify cytotoxic CD4+ tissue-resident memory T cells as potential asthma triggers, particularly in older male patients. These cells can cause severe inflammatory responses and make treatment challenging.
The Center for Advancing Point of Care Technologies (CAPCaT) has received a five-year, $8.9 million award from the NIH to develop innovative point-of-care health technologies. The program aims to address heart, lung, blood and sleep disorders in underserved populations.
A new study reveals that innate CD8+ lymphocytes play a crucial role in limiting tuberculosis infection, and an inflammatory molecule called Interleukin-15 could be used to boost vaccine efficacy. Researchers found that these cells create a 'bottleneck' preventing bacteria from establishing active infection.
A recent VA study analyzed electronic health records of over 5.9 million veterans to provide insights into COVID-19 mortality rates. The research found that absolute numbers of deaths were higher in younger age groups and healthier individuals, despite older adults experiencing the highest rate of excess mortality.
Researchers at UCSF found a feedback loop between immune protein IL-31 and nerve cells, which dials back nearby inflammation and promotes skin healing. This discovery could lead to new treatments for conditions like eczema, allergies, and asthma by targeting the nervous system's role in regulating the immune response.
Scientists have discovered a TB vaccination strategy that prevents lung infection in monkeys infected with SIV, despite the vaccine being contraindicated for people living with HIV. The results show promise for protecting people with HIV against TB, which is the leading cause of death among them.
A University at Buffalo-led research team has developed molecules that can transport chloride ions across cell membranes, increasing airway surface liquid and restoring normal mucus clearance in cystic fibrosis cells. The synthetic anion binders offer a new potential treatment for the chronic disease.
A new AI tool developed by Brazilian researchers can detect potentially cancerous lung nodules in CT reports, missing a crucial early diagnosis. The NLP tool achieved an accuracy rate of 97% in identifying suspicious nodules.
Researchers discuss lurbinectedin as a method to treat neuroendocrine tumors (NETs), with encouraging results from phase II basket studies demonstrating activity in platinum-sensitive relapsed SCLC and other malignancies. Lurbinectedin's mechanism of action involves inhibiting oncogenic transcription, promoting apoptosis and cell death.
Post-Acute Sequelae of COVID-19 research aims to track long-term health symptoms in survivors. A $3.7 million grant will support the development of self-supervised deep learning technologies to recognize post-COVID lung progression phenotypes.
A machine learning model developed by researchers can predict lung cancer risk with an 83.9% sensitivity, identifying those who need screening for the disease. The model uses just three predictors: age, smoking duration, and pack-years of smoking, making it a simplified approach to determine high-risk populations.
A University of Melbourne research team is developing an oral therapeutic to restore the activity of common antibiotics used to treat community-acquired bacterial pneumonia. The project aims to combat antibiotic-resistant bacteria and reduce healthcare costs, with potential applications in low- and middle-income countries.
Scientists have developed a trivalent vaccine candidate that provides broad and long-lasting protection against COVID-19 infection by delivering the vaccine via the nose. The vaccine triggers a strong neutralizing antibody response and protects mucosal areas, preventing disease symptoms.
A new model developed by Cleveland Clinic researchers can more accurately prioritize patients waiting for a lung transplant, taking into account their disease severity and time on the waiting list. This approach may help reduce waitlist mortality for patients with end-stage lung disease.
A University of Virginia team has developed a new analytical tool using hydrogels to cultivate vascular sprouting from mouse lung tissue, providing new insight into idiopathic pulmonary fibrosis. The research aims to understand the biomechanical and biochemical cues to blood vessels in the lungs during disease progression.
A new editorial paper highlights the importance of including older patients in lung cancer clinical trials, where they are often undertreated due to age-related factors. The paper emphasizes the need for increased collaboration among stakeholders to enhance enrollment and retention of older cancer patients.
A survey by The BMJ found that patients in deprived areas have limited access to vital diagnostic tests for respiratory conditions. Despite NHS promises, GPs report 'troubling' lack of services, while Asthma + Lung UK warns of acute and long-term deterioration without timely diagnosis.
Five lung stem cell variants dominate CF lungs, causing inflammation, fibrosis, and mucin secretion. CFTR modulators fail to suppress these inflammatory variants, suggesting they as key targets for new drugs.
The 'Crystal Ribcage' technology enables scientists to study lung function at a cellular level while maintaining physiological processes. This innovation holds immense potential for understanding lung diseases and developing new treatments.
A study comparing radiologist and AI performance in interpreting 2,000 chest X-rays found that AI tools achieved moderate sensitivity but high false-positive rates. Radiologists outperformed AI in detecting the absence of disease, especially for complex cases.
Researchers have successfully developed a robot that can autonomously navigate through living lung tissue, avoiding vital structures such as airways and blood vessels. This innovation enables surgeons to reach previously inaccessible small tumors, improving treatment outcomes for patients with lung cancer.
Preeclampsia, a major cause of maternal mortality, has increased by 37% in Texas since 2017. A new $1.47 million NIH grant will support research initiatives to address preeclampsia rates in six Panhandle counties.
A recent study by Boston Medical Center and Boston University's Center for Regenerative Medicine discovered that hemogenic endothelial cells in the fetal lung contribute to blood cell formation. This breakthrough expands our understanding of blood development and its relationship with overall health.
The September issue of the CHEST journal features research on long COVID, including a review on exercise pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2. Original studies also explore asthma treatment with albuterol-budesonide inhalers and sleep therapy using oronasal masks.
A study found that ultrasound scans performed by emergency physicians can nearly halve the time patients spend in emergency departments. This technology, known as point-of-care ultrasound (POCUS), enables faster diagnoses and treatment for suspected deep vein thrombosis (DVT).
Researchers have developed a new vaccination method that induces the production of antibodies in mucus, which can disable viruses. This approach has shown promising results in monkeys, suggesting that oral vaccines against SARS-CoV-2 may be more effective and popular than traditional subcutaneous vaccinations.
Scientists have found that lung-resident memory B cells, critical for pulmonary immunity, require interferon-gamma produced by T follicular helper cells to differentiate. These long-lived immune cells migrate to the lungs from draining lymph nodes and lie in wait to react quickly to future infections.
A phase 2 study of idrevloride in hypertonic saline has shown significant improvement in lung function for individuals with primary ciliary dyskinesia. The treatment, an epithelial sodium channel blocker, is safe and well-tolerated, offering hope for newly developed treatments for the rare disease.
Research found alterations in proteins that can affect autophagy, a self-eating process of damaged cells. Healthy newborns showed individual responses to prenatal exposure to air pollution, with some more vulnerable than others. The study aims to understand the impact on breathing problems during infancy and childhood.
Researchers at the University of Missouri have identified a way to improve immunological memory produced by T cells in response to influenza infection, potentially leading to more effective vaccines and treatments. The study found that manipulating a molecular signaling pathway can strengthen and prolong the immune response.
Researchers at Helmholtz Munich developed a non-invasive method using MR imaging to detect early signs of vascular disease associated with chronic pulmonary impairment in premature infants. The study presents a new tool for risk stratification and potential prevention of complications later in life.
A new genetic study revealed the link between type 2 diabetes, lung disorders, and the gastrointestinal tract. The research suggests that individual responses to GLP-1R agonist drugs depend on DNA variants in the target gene, and high blood sugar levels can directly cause lung complications.
Researchers from Trinity College Dublin have made significant discoveries on how lung cells respond to influenza viruses, identifying two key molecular pathways that trigger the release of cytokines and cell death. These findings hold promise for treating people affected by such viruses.
A Michigan Medicine study found that pulmonary embolism death rates remained unchanged over the past decade, with higher mortality rates among men, Black patients, and those from rural areas. The study analyzed over 100,000 deaths related to pulmonary embolism between 2006 and 2019.
A new study reveals that boys who smoke in their early teens may damage the genes of their future children, leading to increased risks of developing asthma, obesity, and low lung function. Researchers investigated epigenetic profiles of 875 people aged 7-50 and found changes associated with fathers' teenage smoking.
A nationwide study found that modern blood thinners (NOACs) reduce the risk of serious bleeding by up to 45 percent compared to traditional drug Waran. Apixaban, a NOAC substance, is associated with a lower risk of bleeding in both short and long-term treatment.
A National Institutes of Health-supported study suggests that adults with obesity may benefit from extracorporeal membrane oxygenation (ECMO) when in intensive care for respiratory failure. The study found lower mortality rates among patients with obesity who received ECMO compared to those without, contradicting previous concerns.
Researchers found significant reductions in microbiome diversity among people with severe symptoms soon after infection. The oral microbiomes of people with shorter cases changed in consistent ways during infection, while those with long cases changed in many different ways.
A new NIH study found that high levels of certain minerals and metals in environmental water supplies may increase the risk of nontuberculous mycobacteria pulmonary infections in people with cystic fibrosis. The presence of sulfate, vanadium, and molybdenum was positively associated with increased incidence of lung infections.
HSE biologists explain how coronavirus evolves from Wuhan variant to Omicron, highlighting the crucial role of microRNA molecules in the process. The study found that substitutions in the viral genome disrupted microRNA binding regions, leading to the emergence of more contagious and resilient strains.
Researchers discuss the essential role of macrophages in metastatic growth of lung colonies in melanoma, highlighting their importance in clearing challenges to tissue integrity and promoting growth-related processes. The authors emphasize the need for targeted therapies against macrophages to combat untreatable metastasis.
A new University of Michigan poll suggests that nearly half of older adults do not know about the new RSV vaccines, while some groups show much less interest in getting the vaccine. The virus poses a significant risk to older adults with lung or immune system conditions, and those who live in nursing homes.
SARS-CoV-2's nucleocapsid protein (N) uses human body temperature to replicate, binding to RNA motifs at specific spatial folds. The study reveals new functions and potential targets for antiviral drugs.
Researchers found that dietary AHR ligands from cruciferous vegetables, such as kale and broccoli, maintain a healthy barrier in the lungs and prevent infection. The study shows that AHR activity is essential for lung barrier integrity during viral infections.
Researchers found that the flu blocks lung liquid secretion, allowing staph to infect lungs. Treatment with a CFTR-activating drug like ivacaftor restores liquid secretion and protects against staph infection.
A new imaging method developed by UC researchers can identify specific lung infections in real time, reducing diagnosis time from 2-3 days to hours. The method uses injectable probes that light up under a nuclear imaging machine, enabling faster treatment for critically ill patients.
A network meta-analysis found that breathing training combined with aerobic exercise, and yoga training, enhance lung function in adults with asthma. The study highlights the importance of integrating appropriate exercise training into asthma management plans.